Verify Hexarelin Purity — Lab Testing & Quality Standards
Research published in the Journal of Pharmaceutical and Biomedical Analysis found that unverified peptide samples showed purity variance exceeding 15% between claimed and actual composition. A gap that renders experimental protocols unreliable. When hexarelin purity drops below 98%, the presence of truncated sequences, oxidised fragments, and synthesis byproducts introduces variables that confound dosage calculations and mechanistic studies. Our team has worked with research institutions for years, and the single most common protocol failure stems not from experimental design but from unverified peptide quality at the procurement stage.
How do you verify hexarelin purity before use in research protocols?
To verify hexarelin purity, request third-party HPLC (high-performance liquid chromatography) analysis with a Certificate of Analysis (COA) showing purity ≥98%, mass spectrometry confirmation of molecular weight (887.04 g/mol for hexarelin acetate), and sterility testing. Visual inspection alone cannot detect oxidised amino acids or truncated sequences that compromise peptide function. HPLC separates compounds by retention time, quantifying the target peptide against impurities with precision below 0.5%.
The assumption that white lyophilised powder indicates purity is a foundational error. Appearance provides zero insight into molecular integrity. Peptide degradation begins during synthesis if coupling reagents aren't purged completely, continues during lyophilisation if residual moisture remains above 2%, and accelerates during storage if temperature exceeds −20°C for extended periods. This article covers the exact HPLC parameters that confirm hexarelin quality, what COA documentation must include to be valid, and which degradation markers signal a compromised sample.
Why Third-Party HPLC Testing Is Non-Negotiable
Hexarelin is a six-amino-acid synthetic peptide (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂) that stimulates growth hormone secretion through ghrelin receptor agonism. The molecule's biological activity depends entirely on correct amino acid sequencing and the integrity of the C-terminal amide group. A single substitution or oxidation renders the compound inactive. When you verify hexarelin purity through HPLC, you're measuring the percentage of correctly sequenced, unoxidised hexarelin molecules in the sample against truncated sequences, deletion peptides, and synthesis contaminants.
A legitimate COA lists purity as a percentage derived from peak area integration. The target peptide's chromatographic peak divided by total peak area. Research-grade hexarelin should show ≥98% purity by HPLC with peak retention time matching the reference standard. The COA must also include mass spectrometry data confirming molecular weight within ±0.5 Da of the theoretical value (887.04 g/mol for hexarelin acetate salt). Without MS confirmation, HPLC alone can't distinguish hexarelin from a structurally similar contaminant with identical retention time.
Bacterial endotoxin testing (LAL assay) is the third required metric. Peptides synthesised in non-sterile environments or stored improperly accumulate endotoxins that trigger immune responses in cell culture and animal models. The FDA guideline for injectable research compounds is <5 EU/mg. Samples exceeding this threshold introduce inflammatory variables independent of the peptide's pharmacological action. Real Peptides provides third-party COAs for every batch, with HPLC purity verification and endotoxin quantification documented before shipment.
Physical and Chemical Degradation Markers
When you verify hexarelin purity, you're screening for specific degradation pathways that occur post-synthesis. Tryptophan oxidation is the most common. The two Trp residues in hexarelin are highly susceptible to oxidative damage from light exposure, residual peroxide in synthesis reagents, or storage above −20°C. Oxidised Trp generates chromatographic peaks with slightly shorter retention times than native hexarelin, visible as 'shoulder peaks' adjacent to the main peptide peak on HPLC traces. Even 2–3% oxidised Trp can reduce receptor binding affinity by 40% or more.
The C-terminal amide group (–NH₂) is the second vulnerability. Hydrolysis converts the amide to a carboxylic acid, a modification that abolishes hexarelin's ghrelin receptor activity entirely. This degradation pathway accelerates in reconstituted peptides stored above 4°C or in solutions with pH outside the 5.0–7.0 range. HPLC paired with electrospray ionisation mass spectrometry (ESI-MS) detects this modification as a +1 Da shift in molecular weight. The mass difference between –NH₂ and –OH.
Aggregation is the third failure mode. Hexarelin monomers form dimers, trimers, or larger aggregates through disulfide cross-linking (if cysteine contaminants are present) or hydrophobic interactions. Aggregated peptides appear as high-molecular-weight peaks in size-exclusion chromatography (SEC) or as insoluble precipitate in reconstituted vials. A sample showing >2% aggregate content by SEC fails research-grade specifications. Aggregates don't bind receptors and can trigger immune responses in vivo.
Certificate of Analysis: What Valid Documentation Requires
A COA is only as reliable as the testing laboratory that issued it. And here's where most suppliers take shortcuts. To verify hexarelin purity meaningfully, the COA must originate from an ISO/IEC 17025-accredited third-party lab, not an in-house analysis performed by the peptide manufacturer. The conflict of interest is obvious: a supplier testing its own product has financial incentive to report optimistic purity values.
The COA must list the specific HPLC method used. Column type (typically C18 reverse-phase), mobile phase composition (acetonitrile/water gradient with 0.1% TFA), flow rate, detection wavelength (usually 220 nm for peptide bond absorption), and injection volume. Without these parameters, the purity claim can't be reproduced or verified. The chromatogram itself should accompany the COA, showing baseline resolution between the main hexarelin peak and any impurity peaks. Overlapping peaks suggest co-elution. Meaning reported purity may include structurally similar contaminants the method can't distinguish.
Mass spectrometry data must show both the expected molecular ion peak and its isotopic distribution pattern. For hexarelin acetate, the [M+H]⁺ ion appears at m/z 887.04, with secondary peaks at 888.04 and 889.04 representing ¹³C isotopes. A mass spectrum showing only the primary peak without isotope distribution is a fabricated or low-resolution result that doesn't confirm molecular identity. The COA should also state the sample's water content (measured by Karl Fischer titration). Lyophilised peptides absorb atmospheric moisture during storage, and samples exceeding 5% water by weight degrade faster even when frozen.
Key Takeaways
- Third-party HPLC analysis with purity ≥98% is the only method that confirms hexarelin contains correctly sequenced, unoxidised peptide molecules without truncated fragments or synthesis contaminants.
- Mass spectrometry must verify molecular weight within ±0.5 Da of 887.04 g/mol (hexarelin acetate). HPLC purity alone can't distinguish hexarelin from structurally similar impurities with identical retention time.
- Tryptophan oxidation and C-terminal amide hydrolysis are the most common degradation pathways, detectable as shoulder peaks on HPLC traces or +1 Da mass shifts in ESI-MS analysis.
- Valid COAs originate from ISO/IEC 17025-accredited third-party labs and include the full HPLC method parameters, chromatogram, mass spectrum with isotope distribution, and bacterial endotoxin testing below 5 EU/mg.
- Visual inspection of lyophilised powder provides zero information about molecular integrity. White appearance doesn't correlate with purity, sequence accuracy, or oxidation status.
Hexarelin Purity: Testing Method Comparison
| Testing Method | What It Detects | Purity Threshold | Limitations | Professional Assessment |
|---|---|---|---|---|
| HPLC (High-Performance Liquid Chromatography) | Separates hexarelin from impurities by retention time; quantifies target peptide as % of total peak area | ≥98% for research-grade use | Can't distinguish compounds with identical retention time; requires MS confirmation for molecular identity | Gold standard for purity quantification. But only when paired with mass spec and performed by third-party labs |
| Mass Spectrometry (ESI-MS or MALDI-TOF) | Confirms molecular weight (887.04 g/mol for hexarelin acetate) and detects degradation products (oxidised Trp, hydrolysed amide) | Molecular weight within ±0.5 Da of theoretical value | Doesn't quantify purity percentage; must be paired with HPLC for full characterisation | Essential for confirming molecular identity. But can't replace HPLC for purity percentage |
| Bacterial Endotoxin Testing (LAL Assay) | Detects lipopolysaccharide contamination from synthesis or storage in non-sterile environments | <5 EU/mg per FDA guidelines | Doesn't assess peptide purity or sequence accuracy. Only microbial contamination | Non-negotiable for in vivo research. Endotoxins confound immune-related experimental outcomes |
| Visual Inspection | Identifies gross contamination, discolouration, or visible particulate matter in lyophilised powder | N/A. Qualitative only | Provides zero molecular-level information; white powder appearance doesn't correlate with purity or integrity | Useful only as an initial screen. Never a substitute for analytical chemistry |
| Amino Acid Analysis (AAA) | Quantifies individual amino acid content; confirms sequence composition | Measured amino acid ratios must match hexarelin's theoretical composition | Time-consuming, expensive; doesn't detect oxidation or aggregation; rarely performed for routine QC | Historically used for sequence confirmation but largely replaced by MS in modern peptide QC |
What If: Hexarelin Purity Scenarios
What If the Supplier Provides Only an In-House COA?
Request third-party verification from an ISO-accredited lab before proceeding. In-house COAs carry inherent conflict of interest. Suppliers testing their own products have financial incentive to report favourable results. Independent labs like Analytical Chemistry Services or university core facilities provide unbiased analysis. If the supplier refuses third-party testing, assume the peptide doesn't meet claimed specifications. Researchers at institutions with analytical chemistry facilities can verify hexarelin purity on-site using LC-MS if procurement budgets allow equipment access.
What If HPLC Shows 95% Purity Instead of 98%?
A 3% purity gap translates to 3% unknown compounds in your sample. Truncated sequences, oxidised amino acids, or synthesis byproducts that introduce uncontrolled variables into dosage calculations. For dose-response studies or receptor binding assays, this variance is unacceptable. Consider whether your protocol can tolerate this uncertainty or if results will be questioned during peer review. We've found that sub-98% peptides are suitable only for preliminary pilot studies where exact dosage isn't critical. Never for publication-quality work.
What If the Peptide Looks Discoloured After Reconstitution?
Discolouration (yellow, brown, or pink tint) signals oxidation or aggregation that occurred during storage or reconstitution. Don't use the sample. Oxidised hexarelin binds ghrelin receptors with reduced affinity, and aggregates can trigger immune responses in cell culture or animal models. Lyophilised hexarelin should reconstitute to a clear, colourless solution. If discolouration appears immediately upon adding bacteriostatic water, the peptide degraded before reconstitution. Likely due to temperature excursion during shipping or storage above −20°C.
The Unvarnished Truth About Peptide Purity Claims
Here's the honest answer: most research peptides sold online don't meet the purity standards their websites claim. The barrier to entry for peptide reselling is effectively zero. Anyone can purchase bulk powder from overseas manufacturers, repackage it in sterile vials, and market it as 'research grade' without performing any quality testing. We've reviewed hundreds of supplier websites in this space, and fewer than 20% provide batch-specific third-party COAs with traceable lot numbers. The rest offer generic 'sample COAs' that may not correspond to the actual product shipped.
The economic incentive is clear: third-party HPLC-MS testing costs $400–800 per batch. For suppliers moving high volume on thin margins, that expense eliminates profitability unless they charge premium prices. The result is a market where 'cheap' hexarelin frequently means low-purity peptide with undisclosed contaminants. And researchers discover this only after months of inconsistent experimental results. If a supplier's pricing is significantly below market rate and they don't provide batch-specific third-party COAs, assume the purity claim is aspirational rather than verified.
When you verify hexarelin purity through rigorous third-party testing, you're not paying for a piece of paper. You're eliminating the single largest source of experimental error in peptide-based research. The difference between 98% and 92% purity isn't academic. It's the difference between reproducible dose-response curves and data that can't be replicated. Every institution we've worked with that switched from low-cost suppliers to verified high-purity sources reported immediate improvement in protocol consistency. That's not marketing. That's the mechanistic reality of working with chemically defined compounds.
Researchers who want to verify hexarelin purity before use should demand batch-specific COAs from ISO-accredited labs, compare chromatograms across multiple batches for consistency, and consider on-site LC-MS verification if procurement budgets allow. The extra diligence at the procurement stage saves months of troubleshooting failed experiments caused by undetected peptide degradation. Real Peptides provides third-party HPLC-MS verification for every batch because we know institutional researchers can't afford to waste grant funding on compromised compounds.
If the supplier won't provide traceable third-party documentation, your protocol starts with an uncontrolled variable. That's not a risk worth taking.
Frequently Asked Questions
How do you verify hexarelin purity without lab equipment?▼
You cannot verify hexarelin purity without analytical equipment — visual inspection, solubility tests, or ‘feel’ provide zero molecular-level information. The only method that confirms purity is HPLC paired with mass spectrometry, performed by an accredited third-party lab. Request batch-specific Certificates of Analysis (COAs) showing purity ≥98%, molecular weight confirmation at 887.04 g/mol, and bacterial endotoxin levels below 5 EU/mg before accepting any peptide shipment.
What does a valid hexarelin Certificate of Analysis include?▼
A valid COA for hexarelin must include third-party HPLC purity ≥98% with the full chromatogram, mass spectrometry confirming molecular weight within ±0.5 Da of 887.04 g/mol (including isotope distribution pattern), bacterial endotoxin testing below 5 EU/mg via LAL assay, and documentation of the specific HPLC method used (column type, mobile phase, detection wavelength). The COA should originate from an ISO/IEC 17025-accredited lab and include a traceable batch or lot number matching your product.
Why is 98% purity the standard for research-grade hexarelin?▼
The 98% purity threshold ensures that impurities — truncated sequences, oxidised amino acids, synthesis byproducts — constitute less than 2% of the sample, minimising uncontrolled variables in dose-response studies and receptor binding assays. Peptides below 98% purity introduce dosage calculation errors and mechanistic ambiguity that compromise experimental reproducibility. This standard aligns with pharmaceutical-grade peptide specifications and is the minimum acceptable purity for publication-quality research in peer-reviewed journals.
Can you verify hexarelin purity by appearance or smell?▼
No — lyophilised hexarelin should appear as white to off-white powder regardless of purity. Visual inspection cannot detect truncated sequences, oxidised tryptophan residues, or C-terminal amide hydrolysis. Discolouration (yellow, brown, pink) signals degradation that occurred during storage or reconstitution, but a normal appearance doesn’t confirm molecular integrity. HPLC and mass spectrometry are the only methods that verify hexarelin purity at the molecular level.
What happens if hexarelin purity drops below 95%?▼
Sub-95% purity means more than 5% of the sample consists of impurities — potentially including deletion peptides (missing amino acids), oxidised fragments, or aggregated molecules that don’t bind ghrelin receptors. This level of contamination introduces uncontrolled variables into dosage calculations, reduces effective concentration unpredictably, and may trigger immune responses in cell culture or animal models. For publication-quality research, peptides below 95% purity are unsuitable — results will be questioned during peer review due to insufficient compound characterisation.
How do you detect oxidised tryptophan in hexarelin samples?▼
Oxidised tryptophan appears as ‘shoulder peaks’ adjacent to the main hexarelin peak on HPLC chromatograms — these peaks have slightly shorter retention times than native hexarelin. Mass spectrometry confirms oxidation by detecting a +16 Da shift in molecular weight (the mass difference of an added oxygen atom). Hexarelin contains two Trp residues, making it highly susceptible to oxidative degradation from light exposure, residual synthesis reagents, or storage above −20°C.
What is the difference between in-house and third-party COAs?▼
In-house COAs are generated by the peptide supplier testing their own product, creating inherent conflict of interest — they have financial incentive to report favourable results. Third-party COAs originate from independent ISO/IEC 17025-accredited laboratories with no financial relationship to the supplier, providing unbiased verification. Research institutions and regulatory bodies recognise only third-party COAs as valid documentation of peptide purity — in-house testing lacks the independence required for quality assurance.
How often should you verify hexarelin purity during storage?▼
Verify hexarelin purity at procurement (before first use) and re-test if storage conditions were compromised — temperature excursion above −20°C for lyophilised peptide or above 4°C for reconstituted peptide. Peptides stored under stable conditions (−20°C for lyophilised, 2–8°C for reconstituted in bacteriostatic water, protected from light) remain stable for 6–12 months without significant degradation. If experimental results become inconsistent mid-protocol, re-verify purity to rule out peptide degradation as the cause.
Can HPLC purity alone confirm hexarelin quality?▼
No — HPLC purity quantifies the percentage of the target peptide but cannot confirm molecular identity. A contaminant with identical retention time to hexarelin would be incorrectly counted as ‘pure’ hexarelin by HPLC alone. Mass spectrometry must accompany HPLC to verify the molecular weight is 887.04 g/mol (hexarelin acetate) and that no structurally similar impurities are present. The combination of HPLC purity ≥98% plus MS confirmation is the gold standard for peptide verification.
What does bacterial endotoxin testing reveal about hexarelin samples?▼
Bacterial endotoxin testing (LAL assay) detects lipopolysaccharide contamination from non-sterile synthesis environments or improper storage. Endotoxins trigger immune responses in cell culture and animal models independent of hexarelin’s pharmacological action, confounding experimental results. The FDA guideline for injectable research compounds is <5 EU/mg — samples exceeding this threshold introduce inflammatory variables that compromise study validity. Endotoxin testing doesn't assess peptide purity or sequence accuracy; it's a separate sterility verification step.
